(Q53315805)

13 May 2018

title

Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). (English)

1 reference

13 May 2018

author name string

I Kotsianidis

1

1 reference

13 May 2018

I Bouchliou

2

1 reference

13 May 2018

E Nakou

3

1 reference

13 May 2018

E Spanoudakis

4

1 reference

13 May 2018

D Margaritis

5

1 reference

13 May 2018

A V Christophoridou

6

1 reference

13 May 2018

A Anastasiades

7

1 reference

13 May 2018

C Tsigalou

8

1 reference

13 May 2018

G Bourikas

9

1 reference

13 May 2018

A Karadimitris

10

1 reference

13 May 2018

C Tsatalas

11

1 reference

13 May 2018

publication date

20 November 2008

1 reference

13 May 2018

published in

Leukemia

1 reference

13 May 2018

volume

23

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

510-518

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2008.333

exact match

0 references

cites work

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Tregs and rethinking cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Regulatory T-cell compartmentalization and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

The role of the immune system in myelodysplasia: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Regulatory T cells in immune surveillance and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Exploiting regulatory T-cell populations for the immunotherapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

Immunomodulatory drugs in the treatment of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

Myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

Abnormal differentiation of memory T cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.333

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.333

1 reference

13 May 2018

Dimensions Publication ID

1012377157

0 references

1 reference

13 May 2018